Published in Gut on October 26, 2007
A placebo-controlled trial of acotiamide for meal-related symptoms of functional dyspepsia. Gut (2011) 2.66
Review article: current treatment options and management of functional dyspepsia. Aliment Pharmacol Ther (2012) 1.45
Functional Gastrointestinal Disorders Diagnosed by Rome III Questionnaire in Korea. J Neurogastroenterol Motil (2011) 1.36
Functional dyspepsia. Therap Adv Gastroenterol (2010) 1.17
Gastrointestinal eosinophils in health, disease and functional disorders. Nat Rev Gastroenterol Hepatol (2010) 1.06
Current management strategies and emerging treatments for functional dyspepsia. Nat Rev Gastroenterol Hepatol (2013) 1.03
DA-9701: A New Multi-Acting Drug for the Treatment of Functional Dyspepsia. Biomol Ther (Seoul) (2013) 1.00
Translation and validation of the Nepean Dyspepsia Index for functional dyspepsia in China. World J Gastroenterol (2009) 0.90
Treatment of functional dyspepsia with sertraline: a double-blind randomized placebo-controlled pilot study. World J Gastroenterol (2012) 0.88
Itopride therapy for functional dyspepsia: a meta-analysis. World J Gastroenterol (2012) 0.87
Visceral hypersensitivity and electromechanical dysfunction as therapeutic targets in pediatric functional dyspepsia. World J Gastrointest Pharmacol Ther (2014) 0.86
Randomized, Controlled, Multi-center Trial: Comparing the Safety and Efficacy of DA-9701 and Itopride Hydrochloride in Patients With Functional Dyspepsia. J Neurogastroenterol Motil (2015) 0.86
Acupuncture for functional dyspepsia: study protocol for a two-center, randomized controlled trial. Trials (2014) 0.85
Overlap of functional dyspepsia and GERD--diagnostic and treatment implications. Nat Rev Gastroenterol Hepatol (2013) 0.84
Functional dyspepsia today. Maedica (Buchar) (2013) 0.82
Therapeutic effects of famotidine on chronic symptomatic gastritis: subgroup analysis from FUTURE study. J Gastroenterol (2011) 0.81
Bloating and functional gastro-intestinal disorders: where are we and where are we going? World J Gastroenterol (2014) 0.80
Acupuncture for patients with functional dyspepsia: study protocol of a randomised controlled trial. BMJ Open (2013) 0.78
Comparative steady-state pharmacokinetic study of an extended-release formulation of itopride and its immediate-release reference formulation in healthy volunteers. Drug Des Devel Ther (2014) 0.78
Pitfalls in designing trials of functional dyspepsia: the ascent and demise of itopride. Gut (2008) 0.78
Efficacy of DA-9701 (Motilitone) in Functional Dyspepsia Compared to Pantoprazole: A Multicenter, Randomized, Double-blind, Non-inferiority Study. J Neurogastroenterol Motil (2016) 0.78
Prokinetics in the Management of Functional Gastrointestinal Disorders. J Neurogastroenterol Motil (2015) 0.77
Effect of DA-9701 on Gastric Motor Function Assessed by Magnetic Resonance Imaging in Healthy Volunteers: A Randomized, Double-Blind, Placebo-Controlled Trial. PLoS One (2015) 0.77
Current management of functional dyspepsia: impact of Rome III subdivision. Ann Gastroenterol (2012) 0.76
A multicenter randomized trial comparing rabeprazole and itopride in patients with functional dyspepsia in Japan: the NAGOYA study. J Clin Biochem Nutr (2017) 0.75
Functional Dyspepsia: Advances in Diagnosis and Therapy. Gut Liver (2017) 0.75
Efficacy of a potassium-competitive acid blocker for improving symptoms in patients with reflux esophagitis, non-erosive reflux disease, and functional dyspepsia. Biomed Rep (2016) 0.75
Disorders of gastrointestinal hypomotility. F1000Res (2016) 0.75
Effect of DA-9701 on the Normal Motility and Clonidine-induced Hypomotility of the Gastric Antrum in Rats. J Neurogastroenterol Motil (2016) 0.75
Itopride for gastric volume, gastric emptying and drinking capacity in functional dyspepsia. World J Gastrointest Pharmacol Ther (2017) 0.75
Gastroparesis Updates on Pathogenesis and Management. Gut Liver (2017) 0.75
The Implication of Gastric Dysmotility in the Pathophysiology of Functional Dyspepsia. J Neurogastroenterol Motil (2017) 0.75
The phylogeny of prokaryotes. Science (1980) 24.57
Detailed analysis of the higher-order structure of 16S-like ribosomal ribonucleic acids. Microbiol Rev (1983) 23.08
Timing the ancestor of the HIV-1 pandemic strains. Science (2000) 10.42
Secondary structure model for bacterial 16S ribosomal RNA: phylogenetic, enzymatic and chemical evidence. Nucleic Acids Res (1980) 9.50
Secondary structure model for 23S ribosomal RNA. Nucleic Acids Res (1981) 7.12
Effects of a polypill (Polycap) on risk factors in middle-aged individuals without cardiovascular disease (TIPS): a phase II, double-blind, randomised trial. Lancet (2009) 6.83
Community-based treatment of advanced HIV disease: introducing DOT-HAART (directly observed therapy with highly active antiretroviral therapy). Bull World Health Organ (2001) 6.07
Sequence of the 16S Ribosomal RNA from Halobacterium volcanii, an Archaebacterium. Science (1983) 5.66
Consensus statement for diagnosis of obesity, abdominal obesity and the metabolic syndrome for Asian Indians and recommendations for physical activity, medical and surgical management. J Assoc Physicians India (2009) 5.45
The phylogeny of purple bacteria: the alpha subdivision. Syst Appl Microbiol (1984) 4.96
Speaking the same language: treatment outcome definitions for multidrug-resistant tuberculosis. Int J Tuberc Lung Dis (2005) 4.57
Screening for Down's syndrome: effects, safety, and cost effectiveness of first and second trimester strategies. BMJ (2001) 4.15
Were the original eubacteria thermophiles? Syst Appl Microbiol (1987) 4.06
Mianserin hydrochloride: a novel antidepressant. Br J Psychiatry (1976) 3.92
Rooting the archaebacterial tree: the pivotal role of Thermococcus celer in archaebacterial evolution. Syst Appl Microbiol (1988) 3.76
Factors affecting uptake of antenatal HIV testing in London: results of a multicentre study. BMJ (1998) 3.72
Putative introns in tRNA genes of prokaryotes. Proc Natl Acad Sci U S A (1983) 3.60
The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40,000 subjects. Aliment Pharmacol Ther (2003) 3.41
Analgesic efficacy of pre-operative stellate ganglion block on postoperative pain relief: a randomised controlled trial. Anaesthesia (2014) 3.30
Halobacterium volcanii tRNAs. Identification of 41 tRNAs covering all amino acids, and the sequences of 33 class I tRNAs. J Biol Chem (1984) 3.25
Sequence of the 16S rRNA gene from the thermoacidophilic archaebacterium Sulfolobus solfataricus and its evolutionary implications. J Mol Evol (1985) 3.20
Adverse events in the treatment of multidrug-resistant tuberculosis: results from the DOTS-Plus initiative. Int J Tuberc Lung Dis (2004) 2.87
Antimicrobial susceptibility and frequency of occurrence of clinical blood isolates in Europe from the SENTRY antimicrobial surveillance program, 1997 and 1998. Clin Infect Dis (2000) 2.87
Structural basis for the recognition of DNA repair proteins UNG2, XPA, and RAD52 by replication factor RPA. Cell (2000) 2.73
Improvement of gastric emptying in diabetic gastroparesis by erythromycin. Preliminary studies. N Engl J Med (1990) 2.67
Prediction of human protein function according to Gene Ontology categories. Bioinformatics (2003) 2.54
Transcription and excision of a large intron in the tRNATrp gene of an archaebacterium, Halobacterium volcanii. J Biol Chem (1985) 2.45
Differential inhibition of signaling pathways by dominant-negative SH2/SH3 adapter proteins. Mol Cell Biol (1995) 2.44
Randomised clinical trial: otilonium bromide improves frequency of abdominal pain, severity of distention and time to relapse in patients with irritable bowel syndrome. Aliment Pharmacol Ther (2011) 2.42
Acid, nonacid, and gas reflux in patients with gastroesophageal reflux disease during ambulatory 24-hour pH-impedance recordings. Gastroenterology (2001) 2.41
Mutations in the homeobox gene HESX1/Hesx1 associated with septo-optic dysplasia in human and mouse. Nat Genet (1998) 2.34
Development and validation of a patient-assessed gastroparesis symptom severity measure: the Gastroparesis Cardinal Symptom Index. Aliment Pharmacol Ther (2003) 2.28
Activation of Pak by membrane localization mediated by an SH3 domain from the adaptor protein Nck. Curr Biol (1997) 2.24
Weakly acidic reflux in patients with chronic unexplained cough during 24 hour pressure, pH, and impedance monitoring. Gut (2005) 2.20
Blood pressure cuffs: friend or foe? J Hosp Infect (2006) 2.15
Lymphatic manifestations of lymphangioleiomyomatosis. Lymphology (2014) 2.06
With a pinch of salt. Clin Med (2010) 2.06
Prediction of human protein function from post-translational modifications and localization features. J Mol Biol (2002) 2.05
Quantitative neuropathology by high resolution magic angle spinning proton magnetic resonance spectroscopy. Proc Natl Acad Sci U S A (1997) 2.04
Surgical decisions in the elderly: the importance of biological age. J R Soc Med (2001) 2.02
Novel protein kinases associated with calcineurin B-like calcium sensors in Arabidopsis. Plant Cell (1999) 2.02
Effect of Trigonella foenum-graecum (fenugreek) seeds on glycaemic control and insulin resistance in type 2 diabetes mellitus: a double blind placebo controlled study. J Assoc Physicians India (2001) 2.01
Determinants of symptoms in functional dyspepsia: gastric sensorimotor function, psychosocial factors or somatisation? Gut (2008) 2.00
The pleckstrin homology domain of phospholipase C-delta 1 binds with high affinity to phosphatidylinositol 4,5-bisphosphate in bilayer membranes. Biochemistry (1995) 1.84
Clinical trial guidelines for pharmacological treatment of irritable bowel syndrome. Aliment Pharmacol Ther (2003) 1.82
Atrial fibrillation detected by mobile cardiac outpatient telemetry in cryptogenic TIA or stroke. Neurology (2008) 1.80
Recombination activities of HsDmc1 protein, the meiotic human homolog of RecA protein. Proc Natl Acad Sci U S A (1997) 1.79
The phylogenetic relationships of three sulfur dependent archaebacteria. Syst Appl Microbiol (1984) 1.79
Development and psychometric evaluation of the patient assessment of upper gastrointestinal symptom severity index (PAGI-SYM) in patients with upper gastrointestinal disorders. Qual Life Res (2004) 1.76
Pseudomonas aeruginosa community-acquired pneumonia in previously healthy adults: case report and review of the literature. Clin Infect Dis (2000) 1.72
Investigation of apparent diffusion coefficient and diffusion tensor anisotrophy in acute and chronic multiple sclerosis lesions. AJNR Am J Neuroradiol (1999) 1.72
Waist circumference cutoff points and action levels for Asian Indians for identification of abdominal obesity. Int J Obes (Lond) (2006) 1.71
Total hip arthroplasty in ankylosing spondylitis: outcome in 340 patients. J Rheumatol (2001) 1.71
Multiple retinal haemorrhages (decompression retinopathy) following paracentesis for macular branch artery occlusion. Eye (Lond) (2005) 1.70
Improved survival in the treatment of squamous carcinoma of the oral tongue. Am J Surg (1993) 1.69
Amphotericin B lipid complex compared with amphotericin B in the treatment of cryptococcal meningitis in patients with AIDS. Clin Infect Dis (1996) 1.68
Relationship between symptoms and ingestion of a meal in functional dyspepsia. Gut (2008) 1.67
Prevalence of tobacco use and awareness of risks among school children in Jaipur. J Assoc Physicians India (2006) 1.66
Dendritic cells genetically engineered to express IL-4 inhibit murine collagen-induced arthritis. J Clin Invest (2001) 1.66
Distinction between hyperaldosteronism due to bilateral hyperplasia and unilateral aldosteronoma: reliability of CT. Radiology (1992) 1.66
Effect of a chimeric antibody to tumor necrosis factor-alpha on cytokine and physiologic responses in patients with severe sepsis--a randomized, clinical trial. Crit Care Med (1998) 1.65
Relevance of ineffective oesophageal motility during oesophageal acid clearance. Gut (2003) 1.61
Phenotypic spectrum of neurodegeneration associated with mutations in the PLA2G6 gene (PLAN). Neurology (2008) 1.60
The nuclear eicosanoid receptor, PPARgamma, is aberrantly expressed in colonic cancers. Carcinogenesis (1998) 1.59
Cannabinoid receptor 1 signalling dampens activity and mitochondrial transport in networks of enteric neurones. Neurogastroenterol Motil (2009) 1.59
Posttranscriptional modification of tRNA in thermophilic archaea (Archaebacteria). J Bacteriol (1991) 1.57
Mouse B7-H3 induces antitumor immunity. Gene Ther (2003) 1.57
Study of the mass and spin-parity of the Higgs boson candidate via its decays to Z boson pairs. Phys Rev Lett (2013) 1.56
Randomised clinical trial: effects of monotherapy with ADX10059, a mGluR5 inhibitor, on symptoms and reflux events in patients with gastro-oesophageal reflux disease. Aliment Pharmacol Ther (2011) 1.56
The burden of drug-resistant tuberculosis and mechanisms for its control. Ann N Y Acad Sci (2001) 1.55
Reversible leukoencephalopathy associated with cerebral amyloid angiopathy. Neurology (2004) 1.55
Ambulatory gastrojejunal manometry in severe motility-like dyspepsia: lack of correlation between dysmotility, symptoms, and gastric emptying. Gut (1998) 1.54
Ascitic fluid cholesterol in malignant and tubercular ascites. J Assoc Physicians India (1995) 1.54
Interaction specificity of Arabidopsis calcineurin B-like calcium sensors and their target kinases. Plant Physiol (2000) 1.53
Structure of a modified nucleoside in archaebacterial tRNA which replaces ribosylthymine. 1-Methylpseudouridine. J Biol Chem (1982) 1.51
Associations between gastric sensorimotor function, depression, somatization, and symptom-based subgroups in functional gastroduodenal disorders: are all symptoms equal? Neurogastroenterol Motil (2012) 1.51
Assessment of gastric sensorimotor function in paediatric patients with unexplained dyspeptic symptoms and poor weight gain. Neurogastroenterol Motil (2007) 1.50
Review article: a comparison of glucagon-like peptides 1 and 2. Aliment Pharmacol Ther (2012) 1.48
Composition of the postprandial refluxate in patients with gastroesophageal reflux disease. Am J Gastroenterol (2001) 1.47
Second-generation antipsychotics and constipation: a review of the literature. Eur Psychiatry (2010) 1.46
ATMPK4, an Arabidopsis homolog of mitogen-activated protein kinase, is activated in vitro by AtMEK1 through threonine phosphorylation. Plant Physiol (2000) 1.46
Psoas abscess - not as rare as we think? Colorectal Dis (2007) 1.45
Different regional brain activity during physiological gastric distension compared to balloon distension: a H2 15O-PET study. Neurogastroenterol Motil (2010) 1.45
Role of recombinant human erythropoietin in patients of advanced cervical cancer treated "by chemoradiotherapy". Cancer Biol Ther (2009) 1.44
Quantitative food frequency questionnaire and assessment of dietary intake. Natl Med J India (1999) 1.44
Review article: acidity and volume of the refluxate in the genesis of gastro-oesophageal reflux disease symptoms. Aliment Pharmacol Ther (2007) 1.44
Recurrence and progression in stage T1G3 bladder tumour with intravesical bacille Calmette-Guérin (Danish 1331 strain). BJU Int (2002) 1.44
Multiple rapid swallowing: a complementary test during standard oesophageal manometry. Neurogastroenterol Motil (2009) 1.43
Comparison between low and high pressure suction drainage following axillary clearance. Eur J Surg Oncol (2000) 1.43
Prevalence, risk factors and awareness of hypertension in India: a systematic review. J Hum Hypertens (2012) 1.43
Cervical tuberculous lymphadenopathy: changing clinical pattern and concepts in management. Postgrad Med J (2001) 1.42
Pneumatic dilation for achalasia--the way forward. Aliment Pharmacol Ther (2011) 1.40
Extraoesophageal manifestations of gastro-oesophageal reflux. Gut (2005) 1.40
Diabetes and heat shock protein. Nature (1992) 1.40
Persistence of cell-mediated and humoral immune responses in healthy children immunized with live attenuated varicella vaccine. J Infect Dis (1994) 1.39
Role of transforming growth factor Beta in corneal function, biology and pathology. Curr Mol Med (2010) 1.39
Life-threatening diarrhea after short-term misoprostol use in a patient with Crohn ileocolitis. Ann Intern Med (1990) 1.39
Hypokalaemia mimicking Guillain-Barre syndrome. J Assoc Physicians India (1989) 1.39
A method to facilitate nasoenteral feeding tube placement. Anaesth Intensive Care (2005) 1.39
Autoinoculation lupus vulgaris of the perineum. Genitourin Med (1991) 1.39